XBIT News and Press, XBiotech Inc. From 07/14/20

Antibody Therapy Targeting Interleukin-1a significantly reduced stroke related brain injury in animals and points to new potential blockbuster therapy AUSTIN, Texas, July 14, 2020 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today findings published in the prestigious American...

Ultra-thinly traded micro cap Liminal BioSciences ( LMNL +129.1% ) is up on a whopping 105x surge in volume, albeit on a relatively modest 1.2M shares, in reaction to its announcement that subsidiary Prometic Plasma Resources has started collecting convalescent plasma from people who hav...

XBiotech ( XBIT +3.4% ) announces that it has identified human immune donors that can support the development of a True Human antibody therapy for COVID-19. More news on: XBiotech Inc., Healthcare stocks news, Stocks on the move, Read more ...

Donors with Potent Natural Immunity Against the Virus are Identified as the Starting Point for XBiotech’s Drug Development Program to Treat COVID-19 AUSTIN, Texas, May 01, 2020 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today that human immune donors have now been i...

Montefiore Health System, Albert Einstein College of Medicine and NYU Langone have initiated a clinical trial evaluating the efficacy of convalescent plasma in COVID-19 patients. More news on: XBiotech Inc., Cerus Corporation, ThermoGenesis Holdings, Inc., Healthcare stocks news, Stocks ...

AUSTIN, Texas, April 14, 2020 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today that a novel antibody it has discovered that neutralizes interleukin-1 alpha (IL-1⍺) has now been advanced as a product candidate for clinical and commercial development. XBiotech discovere...

GlaxoSmithKline's Nucala Achieves Co-Primary Endpoints GlaxoSmithKline ( GSK ) announced that its drug candidate Nucala met co-primary endpoints for the pivotal SYNAPSE study. The trial was designed to assess the efficacy of this asthma drug in treating patients with nasal polyps associa...

Immunomedics (NASDAQ: IMMU ) +111%  on positive ADC data in breast cancer. More news on: Immunomedics, Inc., Two Harbors Investment Corp., Mesoblast Limited, Stocks on the move, , Read more ...

Following up on its initial announcements in January and February , Incyte (NASDAQ: INCY ) reports detailed results from two successful Phase 3 clinical trials, TRuE-AD1 and TRuE-AD2 , evaluating a topical cream formulation of kinase inhibitor ruxolitinib in adolescents and adults wi...

XBiotech (NASDAQ: XBIT ) will collaborate with non-profit BioBridge Global in an FDA program to collect and distribute convalescent plasma from people who have recovered from COVID-19 infection. More news on: XBiotech Inc., Healthcare stocks news, Stocks on the move, Read more ...